Computed Tomography Reflects Lower Airway Inflammation and Tracks Changes in Early Cystic Fibrosis-Reference-Cited by-同舟云学术

Computed Tomography Reflects Lower Airway Inflammation and Tracks Changes in Early Cystic Fibrosis

Published:2007-05 Issue:9 Volume:175 Page:943-950
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Davis Stephanie D.,Fordham Lynn A.,Brody Alan S.,Noah Terry L.,Retsch-Bogart George Z.,Qaqish Bahjat F.,Yankaskas Bonnie C.,Johnson Robin C.,Leigh Margaret W.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference44 articles.

1. Khan TZ, Wagener JS, Boat T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis.Am J Respir Crit Care Med1995;151:1075–1082.

2. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

3. Jacobsen LE, Houston CS, Habbick BF, Genereux GP, Howie JL. Cystic fibrosis: a comparison of computed tomography and plain chest radiographs.Can Assoc Radiol J1986;37:17–21.

4. Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study.

5. Computed Tomography in the Evaluation of Cystic Fibrosis Lung Disease

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa;Pneumologie;2024-02-13

2. MR Perfusion Imaging of the Lung;Magnetic Resonance Imaging Clinics of North America;2024-02

3. Deep Learning Approaches for Quantifying Ventilation Defects in Hyperpolarized Gas Magnetic Resonance Imaging of the Lung: A Review;Bioengineering;2023-11-23

4. Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study;Frontiers in Pharmacology;2023-09-21

5. The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting;Respiratory Research;2023-08-11